Literature DB >> 10443813

The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease.

G M Campos1, J H Peters, T R DeMeester, S Oberg, P F Crookes, R J Mason.   

Abstract

HYPOTHESIS: There is an independent association between the different patterns of esophageal acid exposure in gastroesophageal reflux disease and the severity of the disease.
DESIGN: Case-comparison study.
SETTING: Department of surgery at a university hospital. PATIENTS: A group of 401 patients with increased esophageal acid exposure divided into 4 groups according to the pattern of reflux: postprandial (n = 41), upright (n = 74), supine (n = 129), and bipositional (n = 157). MAIN OUTCOME MEASURES: The prevalence of mucosal injury and the status of the lower esophageal sphincter and esophageal motility were assessed in each group.
RESULTS: The likelihood of having indicators of the severity of gastroesophageal reflux disease increases progressively from postprandial to upright, supine, and bipositional reflux.
CONCLUSIONS: The pattern of esophageal acid exposure in gastroesophageal reflux disease is an objective predictor of the severity of disease and could be used for therapeutic decisions.

Entities:  

Mesh:

Year:  1999        PMID: 10443813     DOI: 10.1001/archsurg.134.8.882

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  18 in total

Review 1.  Barrett's esophagus.

Authors:  Jeffrey H Peters; Jeffrey A Hagen; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

Review 2.  How should Barrett's ulceration be treated?

Authors:  J H Peters; K K Wang
Journal:  Surg Endosc       Date:  2004-01-12       Impact factor: 4.584

Review 3.  Healing of oesophagitis.

Authors:  L Rodrigo
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus.

Authors:  J H Peters
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

5.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

6.  Once-daily omeprazole/sodium bicarbonate heals severe refractory reflux esophagitis with morning or nighttime dosing.

Authors:  Diana M Orbelo; Felicity T Enders; Yvonne Romero; Dawn L Francis; Sami R Achem; Tushar S Dabade; Michael D Crowell; Debra M Geno; Ramona S DeJesus; Vikneswaran Namasivayam; Steven C Adamson; Amindra S Arora; Andrew J Majka; Jeffrey A Alexander; Joseph A Murray; Matthew Lohse; Nancy N Diehl; Mary Fredericksen; Kee Wook Jung; Margaret S Houston; Angela E O'Neil; David A Katzka
Journal:  Dig Dis Sci       Date:  2014-01-22       Impact factor: 3.199

7.  Effect of "white diet" during bile monitoring with Bilitec 2000 on esophageal pH-metry in patients with gastroesophageal reflux disease.

Authors:  Christian A Gutschow; Elfriede Bollschweiler; Wolfgang Schröder; Peter Collet; Jean-Marie Collard; Arnulf H Hölscher
Journal:  J Gastrointest Surg       Date:  2005-04       Impact factor: 3.452

8.  Prolapse gastropathy syndrome may be a predictor of pathologic acid reflux.

Authors:  Jin-Soo Kim; Hyung-Keun Kim; Young-Seok Cho; Hiun-Suk Chae; Byung-Wook Kim; Jin-Il Kim; Sok-Won Han; Kyu-Yong Choi
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

9.  The effect of hiatal hernia on gastroesophageal reflux disease and influence on proximal and distal esophageal reflux.

Authors:  Nurten Savas; Ulku Dagli; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2008-01-17       Impact factor: 3.199

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.